AIM AHEAD West Hub & Awardee Showcase: Algorithmic Opacity in Opioid Risk Scoring

The National Institutes of Health’s AIM-AHEAD program was established to create mutually beneficial and coordinated partnerships that empower researchers and communities across the United States in developing AI/ML models and enhancing the capabilities of this emerging technology. As part of this effort, Christian Cabunag, will highlight the AIM AHEAD West Hub, housed at UCLA, which supports research, training, and community partnerships across the region. Following this introduction, we will showcase the work of one of our AIM AHEAD Awardees, Dr. Yun “Sherry” Wang, Assistant Professor at Chapman University School of Pharmacy. Dr. Wang will present her research, Algorithmic Opacity in Opioid Risk Scoring: Need for Transparent AI Regulation in Healthcare, which explores the implications of AI use in clinical decision-making and the urgent need for transparency in healthcare algorithms.

Speakers:

Christian Cabunag, MPP and Yun “Sherry” Wang, Ph.D